OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Remdesivir for the Treatment of Covid-19 — Final Report
John H. Beigel, Kay M Tomashek, Lori E. Dodd, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 19, pp. 1813-1826
Open Access | Times Cited: 7135

Showing 26-50 of 7135 citing articles:

SARS-CoV-2 viral load is associated with increased disease severity and mortality
Jesse Fajnzylber, James Regan, Kendyll Coxen, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 848

SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology
Flávio P. Veras, Marjorie Cornejo Pontelli, Camila M. Silva, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 12
Open Access | Times Cited: 843

Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Peter Horby, Wei Shen Lim, Jonathan Emberson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 812

Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Siemieniuk, Jessica Bartoszko, Dena Zeraatkar, et al.
BMJ (2020), pp. m2980-m2980
Open Access | Times Cited: 796

COVID-19 and multisystem inflammatory syndrome in children and adolescents
Li Jiang, Kun Tang, Michael Levin, et al.
The Lancet Infectious Diseases (2020) Vol. 20, Iss. 11, pp. e276-e288
Open Access | Times Cited: 792

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
Derek C. Angus, Lennie Derde, Farah Al-Beidh, et al.
JAMA (2020) Vol. 324, Iss. 13, pp. 1317-1317
Open Access | Times Cited: 761

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux, et al.
JAMA Internal Medicine (2020) Vol. 181, Iss. 1, pp. 32-32
Open Access | Times Cited: 722

COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. García-Beltrán, Evan C. Lam, Michael G. Astudillo, et al.
Cell (2020) Vol. 184, Iss. 2, pp. 476-488.e11
Open Access | Times Cited: 714

COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment
Anant Parasher
Postgraduate Medical Journal (2020) Vol. 97, Iss. 1147, pp. 312-320
Open Access | Times Cited: 705

Acute respiratory distress syndrome
Nuala J. Meyer, Luciano Gattinoni, Carolyn S. Calfee
The Lancet (2021) Vol. 398, Iss. 10300, pp. 622-637
Open Access | Times Cited: 701

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
David E. Gordon, Joseph Hiatt, Mehdi Bouhaddou, et al.
Science (2020) Vol. 370, Iss. 6521
Open Access | Times Cited: 672

Shermo: A general code for calculating molecular thermochemistry properties
Tian Lu, Qinxue Chen
Computational and Theoretical Chemistry (2021) Vol. 1200, pp. 113249-113249
Open Access | Times Cited: 662

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
Robert Gottlieb, Carlos Vaca, Roger Paredes, et al.
New England Journal of Medicine (2021) Vol. 386, Iss. 4, pp. 305-315
Open Access | Times Cited: 633

COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
Mitra K. Nadim, Lui G. Forni, Ravindra L. Mehta, et al.
Nature Reviews Nephrology (2020) Vol. 16, Iss. 12, pp. 747-764
Open Access | Times Cited: 612

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
David Halpin, Gerard J. Criner, Alberto Papi, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 203, Iss. 1, pp. 24-36
Open Access | Times Cited: 612

Long COVID in a prospective cohort of home-isolated patients
Bjørn Blomberg, Kristin Greve-Isdahl Mohn, Karl A. Brokstad, et al.
Nature Medicine (2021) Vol. 27, Iss. 9, pp. 1607-1613
Open Access | Times Cited: 600

Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
Florian Kabinger, Carina Stiller, Jana Schmitzová, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 9, pp. 740-746
Open Access | Times Cited: 597

The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
Jatin Machhi, Jonathan Herskovitz, Ahmed M. Senan, et al.
Journal of Neuroimmune Pharmacology (2020) Vol. 15, Iss. 3, pp. 359-386
Open Access | Times Cited: 587

Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells
Zharko Daniloski, Tristan X. Jordan, Hans‐Hermann Wessels, et al.
Cell (2020) Vol. 184, Iss. 1, pp. 92-105.e16
Open Access | Times Cited: 567

Artificial intelligence in COVID-19 drug repurposing
Yadi Zhou, Fei Wang, Jian Tang, et al.
The Lancet Digital Health (2020) Vol. 2, Iss. 12, pp. e667-e676
Open Access | Times Cited: 535

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
Caleb P Skipper, Katelyn A Pastick, Nicole Engen, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 8, pp. 623-631
Open Access | Times Cited: 533

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Goran Kokić, Hauke S. Hillen, Dimitry Tegunov, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 533

Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
Betty Raman, David A. Bluemke, Thomas F. Lüscher, et al.
European Heart Journal (2022) Vol. 43, Iss. 11, pp. 1157-1172
Open Access | Times Cited: 526

Modeling COVID-19 scenarios for the United States
Robert C. Reiner, Ryan M Barber, James K. Collins, et al.
Nature Medicine (2020) Vol. 27, Iss. 1, pp. 94-105
Open Access | Times Cited: 521

Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
Michael J. Joyner, Rickey E. Carter, Jonathon W. Senefeld, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 11, pp. 1015-1027
Open Access | Times Cited: 513

Scroll to top